Rockville, Maryland--(Newsfile Corp. - November 21, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (SHPH) (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced that it has closed the acquisition ...
Cellares and Cabaletta Bio announced Wednesday the successful completion of the manufacturing Technology Adoption Program (TAP) using the Cell Shuttle platform. NJBIZ has reported extensively about ...
Technology Adoption Program (TAP) program success demonstrates the ability of Cellares’ IDMO Smart Factory to automate, lower costs and scale out manufacturing for Cabaletta Bio’s clinical-stage CAR T ...
As demand for CAR T therapies strain traditional manufacturing, Autolus Therapeutics has tapped Cellares to evaluate whether that company’s automated Cell Shuttle platform can support expanded ...
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2023 /PRNewswire/ -- Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results